Fig. 1From: RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancersRUNX1 expression analysis in pan-cancer. A. Increased or decreased RUNX1 in datasets of different cancers compared with normal tissues in the Gent2 database; B. RUNX1 expression profile across all tumor samples and paired normal tissues determined by TIMER database. * P < 0.05; ** P < 0.01; *** P < 0.001Back to article page